Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): Double blind randomised controlled trial
Michael J. Kovacs, Philip S. Wells, David R. Anderson, Alejandro Lazo-Langner, Clive Kearon, Shannon M. Bates, Mark Blostein, Susan R. Kahn, Sam Schulman, Elham Sabri, Susan Solymoss, Tim Ramsay, Erik Yeo, Marc A. Rodger
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): Double blind randomised controlled trial'. Together they form a unique fingerprint.